Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025
08:10am, Tuesday, 14'th Oct 2025
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker will showcase new additions to its trauma offerings at the Orthopaedic Trauma Association Annual Meeting, October 15–18, in Phoenix, Ariz.
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 08'th Oct 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the bette
Stryker to announce financial results for its third quarter of fiscal year 2025
08:00am, Wednesday, 01'st Oct 2025
Portage, Michigan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its third quarter of fiscal year 2025 on Thursday, October 30, 2025. A pre
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
09:51am, Wednesday, 24'th Sep 2025
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
01:36pm, Monday, 22'nd Sep 2025
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Monday, 22'nd Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two companies is the best option for those l
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
11:06am, Thursday, 18'th Sep 2025
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Stryker Launches Incompass Total Ankle System at AOFAS 2025
07:20am, Tuesday, 09'th Sep 2025
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker will launch its Incompass™ Total Ankle System at the 2025 AOFAS Annual Meeting in Savannah, Georgia, September 10–13, 2025 (booth # 401).
Stryker Corporation (SYK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
05:33pm, Thursday, 04'th Sep 2025
Stryker Corporation (NYSE:SYK ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Jason Beach - Vice President of Finance & Investor Relations J. Pi
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 02'nd Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value oppo
Investing in the Age of Longevity: Silver Economy Stocks in Focus
01:16pm, Monday, 01'st Sep 2025
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
Stryker's Robotics and Global Gains Offset by Macro Concerns
10:56am, Friday, 22'nd Aug 2025
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
Stryker Q2: Record Mako Installation And High Utilization
02:55pm, Tuesday, 19'th Aug 2025
I reiterate a Hold rating on Stryker Corporation, with a fair value of $382 per share, despite recent strong quarterly results. Stryker's Mako installations and utilization remain robust, and upcoming
Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares
01:50pm, Tuesday, 19'th Aug 2025
Stryker continues to outperform peers with strong revenue growth, margin expansion, and successful product innovation. Recent quarterly results beat expectations, driven by robust performance across t
Stryker (SYK) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Monday, 18'th Aug 2025
Stryker (SYK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
